Whittier Trust CO Of Nevada Inc Corvus Pharmaceuticals, Inc. Transaction History
Whittier Trust CO Of Nevada Inc
- $4.02 Billion
- Q4 2024
A detailed history of Whittier Trust CO Of Nevada Inc transactions in Corvus Pharmaceuticals, Inc. stock. As of the latest transaction made, Whittier Trust CO Of Nevada Inc holds 11,200 shares of CRVS stock, worth $48,271. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,200
Previous 11,200
-0.0%
Holding current value
$48,271
Previous $59,000
1.69%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding CRVS
# of Institutions
102Shares Held
38.1MCall Options Held
2.75MPut Options Held
1.17M-
Orbimed Advisors LLC San Diego, CA6.94MShares$29.9 Million0.98% of portfolio
-
Samlyn Capital, LLC New York, NY6.67MShares$28.7 Million0.56% of portfolio
-
Adams Street Partners LLC Chicago, IL3.28MShares$14.1 Million18.22% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct3.03MShares$13.1 Million0.04% of portfolio
-
Rtw Investments, LP New York, NY2.68MShares$11.5 Million0.23% of portfolio
About Corvus Pharmaceuticals, Inc.
- Ticker CRVS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,553,500
- Market Cap $201M
- Description
- Corvus Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology therapies. Its lead product candidate is Mupadolimab (CPI-006), an anti-CD73 monoclonal antibody, which is in Phase Ib/II clinical trial for non-small cell lung cancer and head and neck cancers. The compan...